Biobanking and Regenerative Medicine

Regenerative medicine and tissue engineering play significant roles in the treatment of currently intractable conditions, such as chronic heart failure, stroke, chronic osteoarthritis, and other maladies. Regenerative medicine and tissue engineering generally depend on the utilization of stem cells...

Full description

Saved in:
Bibliographic Details
Other Authors: Harris, David (Editor)
Format: Book Chapter
Published: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020
Subjects:
Online Access:Get Fullteks
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 03134naaaa2200661uu 4500
001 doab_20_500_12854_69307
005 20210501
020 |a books978-3-03943-540-1 
020 |a 9783039435401 
024 7 |a 10.3390/books978-3-03943-540-1  |c doi 
041 0 |a English 
042 |a dc 
072 7 |a M  |2 bicssc 
100 1 |a Harris, David  |4 edt 
700 1 |a Harris, David  |4 oth 
245 1 0 |a Biobanking and Regenerative Medicine 
260 |a Basel, Switzerland  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2020 
300 |a 1 electronic resource (100 p.) 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Regenerative medicine and tissue engineering play significant roles in the treatment of currently intractable conditions, such as chronic heart failure, stroke, chronic osteoarthritis, and other maladies. Regenerative medicine and tissue engineering generally depend on the utilization of stem cells to treat patients but may also utilize mature cells that would not normally be considered as stem cells (e.g., skin). Stem cells (like mature cells) may be obtained from many sources in the body including bone marrow, cord blood, cord tissue, adipose tissue, etc. Although stem cells are often used in therapy immediately upon isolation, in many circumstances, the stem and progenitor cells will be harvested, processed and banked frozen until a later time. Biobanking is a convenient alternative to same-day therapeutic use, in that it allows for patient recovery (e.g., from liposuction), provides time to identify the best treatment options, and may allow for multiple interventions with additional patient inconvenience or risk. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
653 |a n/a 
653 |a MSCs 
653 |a EVs 
653 |a exosomes 
653 |a tissue regeneration 
653 |a immunomodulation 
653 |a biobanking 
653 |a adult stem cells 
653 |a ground-state 
653 |a autologous transplantation 
653 |a regenerative medicine 
653 |a stem cell banking 
653 |a newborn stem cells 
653 |a perinatal stem cells 
653 |a umbilical cord tissue 
653 |a umbilical cord blood 
653 |a placenta 
653 |a Vascular tissue engineering 
653 |a human cord blood-derived endothelial cells 
653 |a endothelialization 
653 |a vascular graft 
653 |a Munich Vascular Biobank 
653 |a atherosclerosis 
653 |a human vascular tissue 
653 |a RIN 
653 |a RNA fragmentation 
653 |a adipose tissue 
653 |a cryopreservation 
653 |a autologous 
653 |a fat grafting 
653 |a cryogenic storage 
653 |a lipoaspirate 
653 |a cosmetic surgery 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/3099  |7 0  |z Get Fullteks 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/69307  |7 0  |z DOAB: description of the publication